arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

JUPITER NEUROSCIENCES, INC.

JUNS

$2.35 ▲ +0.01 (+0.43%) at close

15 Visible periods

19 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Neutral Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, JUPITER NEUROSCIENCES, INC. shows solid but mixed fundamentals, with Return on Invested Capital holding up well. Watch FCF / Net Income against typical quality thresholds. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $1.3M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 592.1% ↗

FCF / Share $-4.12 ↘

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 3, 2026.

15-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$24.25K

↑ +30.0% —

Net Income Profit after all expenses

$-2.06M

↓ -34.9% —

FCF / Share Free cash flow per share

$-4.12

↓ -10032.7% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 384.2% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of 0.63x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
EPS Growth YoY (%)	-5728.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-20.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-40.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-250.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	-150.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-150.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	71.4% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-34.9% Weak ↑ Weak Improving Year-over-year change in net income	-34.9% Weak ↑ Weak Improving Year-over-year change in net income	-68.6% Weak ↑ Weak Improving Year-over-year change in net income	-260.8% Weak ↓ Weak Declining Year-over-year change in net income	-141.1% Weak ↓ Weak Declining Year-over-year change in net income	-141.1% Weak ↓ Weak Declining Year-over-year change in net income	-255.6% Weak Weak Year-over-year change in net income	63.7% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	-26.5% Weak Weak Year-over-year change in free cash flow	—	—	—	-1207.2% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
FCF / Net Income (x)	1.11x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	0.70x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	2.42x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.17x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.38x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Return on Invested Capital (%)	592.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	55.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	121.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-3160.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-133.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-27.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	6.8% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	8.2% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	7.5% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	7.3% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	18.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-73.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-49.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-89.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-57.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-576.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-360.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	—	74.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+394%)	140.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+837%)	—	-114.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-861%)	-49.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-433%)	-36.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-344%)	11.0% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-26%)	11.8% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-21%)	10.5% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-30%)	7.4% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-51%)	27.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+86%)	—	—	—

⚖️ Is the balance sheet risky? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Interest Coverage (x)	-33.05x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-16.55x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-27024.15x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	-10534.27x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-19.37x Weak Weak Operating income divided by interest expense Optimal: > 5x	-20.29x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Revenue per Share (USD)	$0.04	$0.00	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-4.08	$-0.06	$-0.07	$-0.07	$-0.07	$-0.05	$-0.05	$-0.02	$0.01	$-0.02	$-0.02	$-0.07	—	—	—
Free Cash Flow per Share (USD)	$-4.12	$-0.04	—	$-0.03	—	$-0.03	—	—	$-0.00	$-0.00	—	—	—	—	—
Book Value per Share (USD)	$-0.55	$-0.08	$-0.05	$0.00	$0.04	$0.09	$0.13	$-0.19	$-0.19	$-0.23	$-0.22	$-0.24	—	—	—
Tangible Book Value per Share (USD)	$-0.55	$-0.08	$-0.05	$0.00	$0.04	$0.09	$0.13	$-0.19	$-0.19	$-0.23	$-0.22	$-0.24	—	—	—
Basic Weighted Avg Shares (shares)	557,567	35.26M	—	34.04M	33.18M	33.10M	—	31.07M	27.54M	26.53M	—	26.40M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Working Capital (USD)	$-1.33M	$-3.32M	$-2.57M	$-886.48K	$191.15K	$1.72M	$2.64M	$-5.68M	—	—	$-5.74M	—	—	—	—
Total Equity (USD)	$-365.97K	$-2.78M	$-1.83M	$57.42K	$1.34M	$3.06M	$4.17M	$-5.75M	$-5.36M	$-6.02M	$-5.80M	$-6.27M	$-8.94M	$-8.48M	$-7.14M

📋 What is driving earnings? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗
Sales/Revenue/Turnover (USD)	$24.25K	$18.65K	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-2.06M	$-2.06M	$-2.58M	$-2.29M	$-1.53M	$-1.53M	$-1.53M	$-634.10K	$-634.10K	$-634.10K	$-429.64K	$-1.75M	—	—	—
Operating Cash Flow (USD)	$-2.29M	$-1.43M	$-2.37M	$-1.15M	—	$-1.06M	$-3.70M	—	$-107.46K	$-65.17K	$-161.14K	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 4 years · 15 quarters

JUPITER NEUROSCIENCES, INC.

Analytical Summary

15-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare JUNS with peers